Dr. Kevin Brown
"PHO is the perfect base for a researcher that wants to have a real impact on the health of Ontarians. At PHO we interact with a wide range of health workers, clinicians and researchers from across the province, so our research stays grounded and is swiftly translated into practice and policy."
Areas of Expertise
- hospital-acquired infection
- C. difficile
- health services research
Academic Degrees and Accreditations
- Doctor of Philosophy (Epidemiology), Dalla Lana School of Public Health, University of Toronto
- Master of Science (Biostatistics), University of North Carolina at Chapel Hill
PHO Research Interests
- Validating medico-administrative and electronic medical record data.
- Identifying facility factors that drive hospital-acquired infection rates.
- Describing patient movement between healthcare facilities and the community.
- Statistical methods for measuring risk factor magnitude and duration.
PHO Research Activities
- Measuring the microbial burden of C. difficile spores on hospital surfaces and in the air and its role in onward transmission of C. difficile and using this information to inform infection control practice.
- Understanding how health care facility antibiotic prescribing patterns and interfacility patient movement impacts the incidence and spread of hospital acquired infections in Ontario.
- Brown KA, Jones A, Daneman N, Chan AK, Schwartz KL, Garber GE, et al. Association between nursing home crowding and COVID-19 infection and mortality in Ontario, Canada. JAMA Intern Med. 2021;181(2):229-36.
- Brown KA, Daneman N, Schwartz KL, Langford B, McGeer A, Quirk J, et al. The urine-culturing cascade: variation in nursing home urine culturing and association with antibiotic use and Clostridiodes difficile infection. Clin Infect Dis. 2020;70(8):1620-7.
- Ulloa AC, Buchan SA, Daneman N, Brown KA. Estimates of SARS-CoV-2 Omicron variant severity in Ontario, Canada. JAMA. 2022;327(13):1286-8.
- Brown KA, Gubbay J, Hopkins J, Patel S, Buchan SA, Daneman N, et al. S-gene target failure as a marker of variant B. 1.1. 7 among SARS-CoV-2 isolates in the Greater Toronto Area, December 2020 to March 2021. JAMA. 2021;325(20):2115-6.
- Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326-32.